by CCI Support Admin | Jan 29, 2026 | Research
This study aimed to identify fibromyalgia genetic risk factors through a combined genetic analysis of over 2.5 million individuals. They had 54,629 fibromyalgia cases and 2,509,126 controls (people without fibromyalgia, used for comparison). They Found: · 26...
by CCI Support Admin | Jan 29, 2026 | Research
Published in Diagnostics (January 2025), this meta-analysis crunches data from 15 studies (over 200 ME/CFS patients vs. controls) to dissect how PEM hijacks your energy systems during exercise provocation. Led by researchers from the Open Medicine Foundation and...
by CCI Support Admin | Jan 13, 2026 | Research
Researchers at Yokohama City University have made a significant breakthrough in understanding the biological basis of cognitive impairment—commonly known as “brain fog”—associated with Long COVID. Although Long COVID’s lasting symptoms affect millions globally and...
by CCI Support Admin | Jan 9, 2026 | Research
The article posits that a broader clinical and research framework — post-acute infection syndromes (PAISs) — is increasingly needed to understand a range of chronic illnesses that can follow acute infections. PAISs include conditions such as long COVID and myalgic...
by CCI Support Admin | Jan 9, 2026 | Research
Scientists in the UK have reported developing what may be the first blood test capable of diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with about 96% accuracy, sparking hope for patients who often wait years for a clinical diagnosis based on...
by CCI Support Admin | Dec 19, 2025 | Research
A major new genetic study on fibromyalgia (FM) involving about 2.5 million people has significantly advanced understanding of the condition by identifying many genetic risk regions associated with FM, placing it on a firm biological foundation rather than being...
